Versant Capital Management’s Eton Pharmaceutcials ETON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.76K Buy
73
+12
+20% +$609 ﹤0.01% 2502
2026
Q2
$2.21K Buy
+61
New +$1.79K ﹤0.01% 2552

Other funds holding ETON

Versant Capital Management's ETON Position: Q3 2026 in Review

Versant Capital Management increased its Eton Pharmaceutcials (ETON) stake by 20% in Q3 2026, buying an estimated $609 and bringing the position to 73 shares worth $3.76K. The position accounts for ﹤0.01% of the portfolio, ranked #2502.

Versant Capital Management first reported a position in ETON in Q2 2026 and has held it in 2 quarters since. 7 funds tracked by Wall St. Rank hold ETON as of Q3 2026.

  • Versant Capital Management held 73 shares of Eton Pharmaceutcials worth $3.76K as of Q3 2026.
  • Versant Capital Management bought 12 Eton Pharmaceutcials shares in Q3 2026, an estimated $609.
  • Eton Pharmaceutcials made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #2502 holding.
  • Versant Capital Management first reported a position in Eton Pharmaceutcials in Q2 2026 and has held it in 2 quarters since.
  • 7 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.